Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07602478
Eccentric Contraction Exercise For Shoulder Pain SyndromeRafeef Hassan AsiriActive Not RecruitingNot Applicable
NCT07602478Active Not Recruiting
Not Applicable
Eccentric Contraction Exercise For Shoulder Pain SyndromeRafeef Hassan Asiri
NCT07603284
Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi ArabiaDexCom, Inc.Active Not RecruitingPhase 4
NCT07603284Active Not Recruiting
Phase 4
Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes o...DexCom, Inc.
NCT07605091
RELIANCE: Moringa in Lactation and Early ChildhoodPhilip KernNot Yet RecruitingNot Applicable
NCT07605091Not Yet Recruiting
Not Applicable
RELIANCE: Moringa in Lactation and Early ChildhoodPhilip Kern
NCT07604558
A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07604558Not Yet Recruiting
Phase 1
A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injectio...AbbVie
NCT07605273
Comparison of 5% Hypertonic Saline Versus 3% Hypertonic Saline in Resolution of Post-operative Corneal Edema.Muhammad Aamir LatifCompletedNot Applicable
NCT07605273Completed
Not Applicable
Comparison of 5% Hypertonic Saline Versus 3% Hypertonic Saline in Resolution of...Muhammad Aamir Latif
NCT07600814
Pain Induced by m-Cresol as PreservativeMedical University of ViennaNot Yet RecruitingEarly Phase 1
NCT07600814Not Yet Recruiting
Early Phase 1
Pain Induced by m-Cresol as PreservativeMedical University of Vie...
NCT07601295
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)National Heart, Lung, and Blood Institute (NHLBI)Not Yet RecruitingPhase 2
NCT07601295Not Yet Recruiting
Phase 2
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of P...National Heart, Lung, and...
NCT07602036
Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyMedtronicNot Yet RecruitingNot Applicable
NCT07602036Not Yet Recruiting
Not Applicable
Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyMedtronic
NCT07602738
Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ.Al-Azhar UniversityCompletedPhase 3
NCT07602738Completed
Phase 3
Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment fo...Al-Azhar University
NCT07603375
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal AdenocarcinomaDuke UniversityNot Yet RecruitingPhase 2
NCT07603375Not Yet Recruiting
Phase 2
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Lo...Duke University
NCT07605195
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Breast Tomosynthesis Based on Deep LearningYunnan Cancer HospitalNot Yet RecruitingNot Applicable
NCT07605195Not Yet Recruiting
Not Applicable
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Bre...Yunnan Cancer Hospital
NCT07600775
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 1
NCT07600775Not Yet Recruiting
Phase 1
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuber...Merck Sharp & Dohme LLC
NCT07602933
Photobiomodulation Effects on Fatigue and Muscle Damage Induced by NMESConselho Nacional de Desenvolvimento Científico e TecnológicoNot Yet RecruitingNot Applicable
NCT07602933Not Yet Recruiting
Not Applicable
Photobiomodulation Effects on Fatigue and Muscle Damage Induced by NMESConselho Nacional de Dese...
NCT07603466
Combination Osilodrostat and Cabergoline in Cushing's DiseaseUniversity of BasrahEnrolling By InvitationPhase 4
NCT07603466Enrolling By Invitation
Phase 4
Combination Osilodrostat and Cabergoline in Cushing's DiseaseUniversity of Basrah
NCT07603219
Nurse-Led Educational Intervention for Caregivers of ICU Patients (Nurses For Family - N4F)Medical University of GdanskNot Yet RecruitingNot Applicable
NCT07603219Not Yet Recruiting
Not Applicable
Nurse-Led Educational Intervention for Caregivers of ICU Patients (Nurses For Fa...Medical University of Gda...
NCT07604766
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in ChinaGenmabNot Yet RecruitingPhase 3
NCT07604766Not Yet Recruiting
Phase 3
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Inv...Genmab
NCT07601009
Validity and Reliability of a Mixed Reality-Based 6-Minute Walk TestSelcuk UniversityRecruiting
NCT07601009Recruiting
—
Validity and Reliability of a Mixed Reality-Based 6-Minute Walk TestSelcuk University
NCT07600827
Isokinetic Training With Blood Flow Restriction for Patellofemoral Pain SyndromeGuilin institute of information technologyRecruitingNot Applicable
NCT07600827Recruiting
Not Applicable
Isokinetic Training With Blood Flow Restriction for Patellofemoral Pain SyndromeGuilin institute of infor...
NCT07603297
Identifying Essential Elements of SAP SupportsChildren's Hospital Medical Center, CincinnatiCompletedNot Applicable
NCT07603297Completed
Not Applicable
Identifying Essential Elements of SAP SupportsChildren's Hospital Medic...
NCT07602881
Blood Exosomal Multi-omics and Lung Radiomics for Predicting Efficacy and Prognosis of Severe Eosinophilic ACOS With BiologicsUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNot Yet Recruiting
NCT07602881Not Yet Recruiting
—
Blood Exosomal Multi-omics and Lung Radiomics for Predicting Efficacy and Progno...Union Hospital, Tongji Me...
Result Breakdown
Not yet recruiting12 (60%)
Completed3 (15%)
Active, not recruiting2 (10%)
Recruiting2 (10%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Phase 42 (10%)
Phase 12 (10%)
Phase 22 (10%)
Phase 32 (10%)
Not Specified2 (10%)
Early Phase 11 (5%)